These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 9468460

  • 1. Cyclosporine-induced hypertension and decline in renal function in healthy volunteers.
    Hansen JM, Fogh-Andersen N, Christensen NJ, Strandgaard S.
    J Hypertens; 1997 Mar; 15(3):319-26. PubMed ID: 9468460
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of felodipine on renal haemodynamics and tubular sodium handling after single-dose cyclosporin infusion in renal transplant recipients treated with azathioprine and prednisolone.
    Madsen JK, Kornerup HJ, Pedersen EB.
    Scand J Clin Lab Invest; 1995 Nov; 55(7):625-33. PubMed ID: 8633187
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin converting enzyme inhibition and chronic cyclosporine-induced renal dysfunction in type 1 diabetes.
    Hannedouche TP, Natov S, Boitard C, Lacour B, Grünfeld JP.
    Nephrol Dial Transplant; 1996 Apr; 11(4):673-8. PubMed ID: 8671857
    [Abstract] [Full Text] [Related]

  • 5. Effect of 6 weeks of vitamin E administration on renal haemodynamic alterations following a single dose of neoral in healthy volunteers.
    Bárány P, Stenvinkel P, Ottosson-Seeberger A, Alvestrand A, Morrow J, Roberts JJ, Salahudeen AK.
    Nephrol Dial Transplant; 2001 Mar; 16(3):580-4. PubMed ID: 11239035
    [Abstract] [Full Text] [Related]

  • 6. Divergent effects of calcium channel and angiotensin converting enzyme blockade on glomerulotubular function in cyclosporine-treated renal allograft recipients.
    Sennesael JJ, Lamote JG, Violet I, Tasse S, Verbeelen DL.
    Am J Kidney Dis; 1996 May; 27(5):701-8. PubMed ID: 8629631
    [Abstract] [Full Text] [Related]

  • 7. Glomerular and tubular function in renal transplant patients treated with and without ciclosporin A.
    Hansen JM, Fogh-Andersen N, Leyssac PP, Strandgaard S.
    Nephron; 1998 Dec; 80(4):450-7. PubMed ID: 9832645
    [Abstract] [Full Text] [Related]

  • 8. Role of angiotensin II in L-NAME-induced systemic and renal hemodynamic effects in hydrochlorothiazide-pretreated hypertensive subjects.
    van der Linde NA, van den Meiracker AH, Boomsma F.
    J Hypertens; 2003 Feb; 21(2):345-51. PubMed ID: 12569265
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans.
    Bech JN, Nielsen CB, Pedersen EB.
    Am J Physiol; 1996 May; 270(5 Pt 2):F845-51. PubMed ID: 8928847
    [Abstract] [Full Text] [Related]

  • 11. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM, de Zeeuw D, van der Hem GK, de Jong PE.
    J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
    [Abstract] [Full Text] [Related]

  • 12. The effect of felodipine on renal function and blood pressure in cyclosporin-treated renal transplant recipients during the first three months after transplantation.
    Madsen JK, Sørensen SS, Hansen HE, Pedersen EB.
    Nephrol Dial Transplant; 1998 Sep; 13(9):2327-34. PubMed ID: 9761517
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure.
    Ljungman S, Aurell M, Hartford M, Wikstrand J, Berglund G.
    Hypertension; 1983 Sep; 5(3):368-74. PubMed ID: 6341220
    [Abstract] [Full Text] [Related]

  • 16. Serial changes in blood pressure, renal function, endothelin and lipoprotein (a) during the first 9 days of cyclosporin therapy in males.
    Sturrock ND, Lang CC, MacFarlane LJ, Dockrell ME, Ryan M, Webb DJ, Struthers AD.
    J Hypertens; 1995 Jun; 13(6):667-73. PubMed ID: 7594425
    [Abstract] [Full Text] [Related]

  • 17. Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease.
    Torres VE, Wilson DM, Burnett JC, Johnson CM, Offord KP.
    Mayo Clin Proc; 1991 Oct; 66(10):1010-7. PubMed ID: 1921483
    [Abstract] [Full Text] [Related]

  • 18. Effects of the prostacyclin analogue iloprost on cyclosporin-induced renal hypoperfusion in stable renal transplant recipients.
    Hansen JM, Christensen NJ, Fogh-Andersen N, Strandgaard S.
    Nephrol Dial Transplant; 1996 Feb; 11(2):340-6. PubMed ID: 8671790
    [Abstract] [Full Text] [Related]

  • 19. Acute renal and immunological effects of low-dose cyclosporin in humans.
    De Nicola L, Libetta C, Memoli B, Bellizzi V, Colucci G, Imperatore P, Taccone W, Oriente L, Sepe V, Conte G.
    Nephrol Dial Transplant; 1995 Feb; 10(9):1739-44. PubMed ID: 8559498
    [Abstract] [Full Text] [Related]

  • 20. Human renal and systemic hemodynamic, natriuretic, and neurohumoral responses to different doses of L-NAME.
    Broere A, Van Den Meiracker AH, Boomsma F, Derkx FH, Veld AJ, Schalekamp MA.
    Am J Physiol; 1998 Dec; 275(6):F870-7. PubMed ID: 9843903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.